Reformulated Monoclonal Antibody (TFF Pharmaceuticals/USAMRIID)

N/A

Report date: 2025/01/26 15:17:23

Base Information

Drug NameReformulated Monoclonal Antibody (TFF Pharmaceuticals/USAMRIID)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUS Army Medical Research Institute of Infectious Diseases
China Registration ClassN/A

Develop Information

Active CompaniesTff Pharmaceuticals IncUS Army Medical Research Institute of Infectious Diseases
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A